Abiopharma

News list

Straube Richard 🟢 acquired 10.0K shares (1 derivative) of SOLIGENIX, INC. (SNGX) at $1.63 Transaction Date: Dec 11, 2025 | Filing ID: 000003

Full text

News bot Dec. 12, 2025, 9:26 p.m.
🔍 Straube Richard (Executive)

Company: SOLIGENIX, INC. (SNGX)

Report Date: 2025-12-11
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 10,000
Detailed Transactions and Holdings:
- Acquired 10,000 shares of Option (Right to Buy) at $1.63 per share (Derivative)
  Date: 2025-12-11 | Code: A | Expires: 2035-12-10 | Exercise: 2025-12-11 | equity_swap_involved: 0 | shares_owned_after: 10,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The stock option vested immediately as to 25% of the shares and vests as to the remaining 75% of the shares in 12 equal installments (or nearly equal installments if the number of remaining shares is not evenly divisible by 12) on each three (3) month anniversary of December 11, 2025.